Application of patient-derived tumor xenograft mouse models in guiding the clinical treatment
10.3969/j.issn.1000-8179.2018.04.838
- VernacularTitle:PDTX小鼠模型在指导肿瘤临床治疗中的应用
- Author:
Huang YUE
1
;
Xuejun ZHU
;
Shouyou HU
Author Information
1. 南京中医药大学附属医院肿瘤科、中心实验室 南京市210029
- Keywords:
tumor;
xenograft;
targeted therapies;
immunodeficient mice;
animal models
- From:
Chinese Journal of Clinical Oncology
2018;45(4):196-200
- CountryChina
- Language:Chinese
-
Abstract:
Patient-derived tumor xenograft(PDTX)models are based on the transfer of primary tumor tissue directly from the patient into immunodeficient mice.PDTX models retain many of the key characteristics of the original cancers,including heterogeneity,histo-logical characteristics,molecular diversities,and host microenvironments.These models do not only serve as platforms for co-clinical trials to determine precisely targeted therapies,but can also be applied to the development of biomarkers and action targets for drug responsiveness and personalized drug selection.PDTX models combined with clinical,genomic,and pharmacodynamic data and ap-plied to the individualized treatment of cancer patients could increase the specificity of drug use,improve clinical treatment success, and promote the development of individualized treatment and precise medical regimes.This review summarizes the historical back-ground,influential modeling factors,clinical applications,and limitations of PDTX mouse models.
